All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for INFECTIOUS DISEASES SOCIETY OF AMERICA · Medical association promoting public health and prevention of infectious diseases

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $50,000.00 income · posted Jan 19, 2026

Official filing document

Bills named in this filing 5

HR 6561
PREVENT HPV Cancers Act of 2025
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
HR 4445
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistance generally H.R. 6561 (PREVENT HPV Cancers Act of 2025), all provisions Infectious diseases physician work force issues generally

Budget/Appropriations

H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill

Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.